Role of thioredoxin 1 and thioredoxin 2 on proliferation of human adipose tissue-derived mesenchymal stem cells

Stem Cells and Development

Volumn 20, Issue 9, 2011, Pages 1529-1537

  Song, Ji Sun ^a,b   Cho, Hyun Hwa ^a,b   Lee, Byung Joo ^b   Bae, Yong Chan ^a   Jung, Jin Sup ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; LUCINE ZIPPER TUMOR SUPPRESSOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; THIOREDOXIN 1; THIOREDOXIN 2; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM;

ADIPOSE TISSUE; ADULT; BUTADIENES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NITRILES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THIOREDOXINS;

LENTIVIRUS; MAMMALIA;

EID: 80052340065     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0364     Document Type: Article

References (39)

1. Holmgren A. (1995). Thioredoxin structure and mechanism: Conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 3:239-243.
2. Nakamura H, K Nakamura and J Yodoi. (1997). Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369.
3. Nordberg J and ES Arner. (2001). Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31:1287-1312.
4. Powis G, D Mustacich and A Coon. (2000). The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29:312-322.
5. Vlamis-Gardikas A and A Holmgren. (2002). Thioredoxin and glutaredoxin isoforms. Methods Enzymol 347:286-296.
6. Psarra AM, S Hermann, G Panayotou and G Spyrou. (2009). Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells. Biochem J 422:521-531.
7. Takagi Y, F Horikawa, K Nozaki, T Sugino, N Hashimoto and J Yodoi. (1998). Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci Lett 251:25-28.
8. Mitsui A, J Hamuro, H Nakamura, N Kondo, Y Hirabayashi, S Ishizaki- Koizumi, T Hirakawa, T Inoue and J Yodoi. (2002). Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 4:693-696.
9. Takaishi S, M Sawada, H Seno, T Kayahara, Y Morita- Fujisawa, H Fukuzawa and T Chiba. (2003). Growth promoting effect of thioredoxin on intestinal epithelial cells. Dig Dis Sci 48:379-385.
10. Schulze PC, GW De Keulenaer, J Yoshioka, KA Kassik and RT Lee. (2002). Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res 91:689-695.
11. Lincoln DT, F Al-Yatama, FM Mohammed, AG Al-Banaw, M Al-Bader, M Burge, F Sinowatz and PK Singal. (2010). Thioredoxin and thioredoxin reductase expression in thyroid cancer depends on tumour aggressiveness. Anticancer Res 30:767-775.
12. Cha MK, KH Suh and IH Kim. (2009). Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. Exp Clin Cancer Res 28:93.
13. Goossens V, K De Vos, D Vercammen, M Steemans, K Vancompernolle, W Fiers, P Vandenabeele and J Grooten. (1999). Redox regulation of TNF signaling. Biofactors 10:145-156.
14. Turrens JF. (2003). Mitochondrial formation of reactive oxygen species. J Physiol 552:335-344.
15. Damdimopoulos AE, A Miranda-Vizuete, M Pelto-Huikko, JA Gustafsson and G Spyrou. (2002). Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 277:33249-33257.
16. Tanaka T, F Hosoi, Y Yamaguchi-Iwai, H Nakamura, H Masutani, S Ueda, A Nishiyama, S Takeda, H Wada, G Spyrou and J Yodoi. (2002). Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21:1695-1703.
17. Zhang R, R Al-Lamki, L Bai, JW Streb, JM Miano, J Bradley and W Min. (2004). Thioredoxin-2 inhibits mitochondrialocated ASK1-mediated apoptosis in a JNK independent manner. Circ Res 94:1483-1491.
18. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
19. Dezawa M, H Kanno, M Hoshino, H Cho, N Matsumoto, Y Itokazu, N Tajima, H Yamada, H Sawada H, H Ishikawa, T Mimura, M Kitada, Y Suzuki and C Ide. (2004). Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113:1701-1710.
20. Dezawa M, H Ishikawa, Y Itokazu, T Yoshihara, M Hoshino, S Takeda, C Ide and Y Nabeshima. (2005). Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309:314-317.
21. Pan RL, Y Chen, LX Xiang, JZ Shao, XJ Dong and GR Zhang. (2008). Fetal liver-conditioned medium induces hepatic specification from mouse bone marrow mesenchymal stromal cells: A novel strategy for hepatic transdifferentiation. Cytotherapy 10:668-675.
22. Meirelles LS, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213.
23. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
24. Rodriguez AM, C Elabd, EZ Amri, G Ailhaud and C Dani. (2005). The human adipose tissue is a source of multipotent stem cells. Biochimie 87:125-128.
25. Gimble JM and F Guilak. (2003). Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol 58:137-160.
26. Lee RH, B Kim, I Choi, H Kim, HS Choi, K Suh, YC Bae and JS Jung. (2004). Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311-324.
27. Das KC. (2001). c-Jun NH2-terminal kinase-mediated redoxdependent degradation of IkB: Role of thioredoxin in NF-kB activation. J Biol Chem 276:4662-4670.
28. Hirota K, M Murata, Y Sachi, H Nakamura, J Takeuchi, K Mori and J Yodoi. (1999). Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kB. J Biol Chem 274:27891-27897.
29. Cho HH, HJ Joo, JS Song, YC Bae and JS Jung. (2008). Crossregulation of β-catenin/Tcf pathway by NF-kB is mediated by lzts2 in human adipose tissue-derived mesenchymal stem cells. Biochim Biophys Acta 1783:419-428.
30. Zhou J, AE Damdimopoulos, G Spyrou and B Brüne. (2007). Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha. J Biol Chem 282:7482-7490.
31. Munemasa Y, JH Ahn, JM Kwong, J Caprioli and N Piri. (2009). Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther 16:17-25.
32. Caprioli J, Y Munemasa, JM Kwong and N Piri. (2009). Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma. Trans Am Ophthalmol Soc 107:161-165.
33. Seger R and EG Krebs. (1995). The MAPK signaling cascade. FASEB J 9:726-735.
34. Arai RJ, FT Ogata, WL Batista, H Masutani, J Yodoi, V Debbas, O Augusto, A Stern and HP Monteiro. (2008). Thioredoxin-1 promotes survival in cells exposed to Snitrosoglutathione: Correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP kinases. Toxicol Appl Pharmacol 233:227-237.
35. McCubrey JA, MM Lahair and RA Franklin. (2006). Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8:1775-1789.
36. Thyssen G, TH Li, L Lehmann, M Zhuo, M Sharma and Z Sun. (2006). LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin. Mol Cell Biol 26:8857-8867.
37. Jeon SH, JY Yoon, YN Park, WJ Jeong, S Kim, EH Jho, YJ Surh and KY Choi. (2007). Axin inhibits extracellular signalregulated kinase pathway by Ras degradation via betacatenin. J Biol Chem 282:14482-14492.
38. Yun MS, SE Kim, SH Jeon, JS Lee and K Choi. (2005). Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 118(Pt 2):313-322.
39. Almeida M, L Han, T Bellido, SC Manolagas and S Kousteni. (2005). Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3- kinase/AKT. J Biol Chem 280:41342-41351.